Key Takeaways
- Record Q2 despite monsoons: Revenue hit the highest Q2 in company history, and YTD order inflow of ~₹3,500 cr has nearly met the full-year target with months to spare.
- Receivables turning the corner: Overall debtors fell ₹90 cr, with 21 days of reduction already achieved; management targets another 20–25 days in H2 and a return to pre-COVID levels by FY27-end.
- Margins guided to the high end: Full-year EBITDA is expected near 17.5% (excluding other income), supported by premium super high-rise work, asset turns approaching 6x, and falling finance costs.
- MHADA unlocks a step-change: The 66-floor commercial tower got the go-ahead, and SPV-level revenue is expected to cross ₹1,000 cr+ in FY27, nearly doubling from current levels.
- What to watch next quarter: Whether the ₹30 cr property sale closes and JJ Hospital receivables release as promised, the pace of debtor reduction toward the 45-day target, and any NGT disruption in North India.
Performance & Receivables
- Highest Q2 ever: The company delivered record Q2 results despite a heavy monsoon, carrying forward momentum from FY25.
- Revenue on track: October billing already reached ₹240 cr; Q3 is targeted at ₹725 cr and March at ₹850 cr, taking the full year to ₹2,810 cr (20% growth). Management has met or surpassed all targets over the last two financial years.
- Debtor reduction underway: March '25 receivables of ₹1,151 cr came down by ₹100 cr in H1; 21 days of reduction already achieved. The earlier doubling of receivables YoY was driven by milestone-based payments on the first design-build EPC projects, a phase that has now passed.
- Receivables recovery: ₹8.69 cr recovered from the Neelkanth client, a slow-moving asset. Long-outstanding trade receivables reported by auditors reduced from ₹63 cr to ~₹55 cr. Against that ₹55 cr, properties worth ₹200 cr are held (all written off); ₹14 cr already sold, and a further ₹30 cr expected to be sold in the current quarter with receivables in November–December.
- Government exposure managed tightly: Only PWD Maharashtra's JJ Hospital faces delays (₹45 cr); presentations have been made to the Medical Education Department for fund allocation. The company will not bid for state government projects that are not fully funded, having "suffered enough in the COVID period." Three main Maharashtra clients (CIDCO, MHADA, MCGM) comprise nearly 50% of revenues going forward, with outstanding only for certified work done.
Katyal: "We have suffered enough in the COVID period. We would not like to land ourselves into another known danger of bidding and then not receiving money from the projects which are not fully funded."
Order Book & Project Pipeline
- Order book at ₹11,991 cr: Public sector 60%, private sector 40%. YTD order inflow of ~₹3,500 cr has nearly achieved the full-year target; management expects to cross it "quite decently," which could mean additional revenue in FY27.
- MHADA transformation: 25 of 34 rehab towers handed over; five more expected in early December 2025. The 66-floor commercial tower received the go-ahead this week; designs expected in Q4. Sale residential tower construction starts January/February, giving a strong indication of nearly doubling SPV-level revenue in FY27 to ₹1,000 cr+. The entire MHADA project will be recognized in the order book by March/April (currently only 35%).
- CIDCO ramp: Expect to bill a further ₹300 cr in H2 and ₹720 cr in FY27, completing six locations. Two locations handed over around 12th December; four more phase-wise in FY26-27 and FY27-28. A seventh location (~₹2,000 cr executable work, 42-month execution) is expected in Q4 and is not yet in FY27 guidance.
- New marquee wins: IIT Bombay Drone Research Center (third industrial project, marquee government client) and Signature Global Phase-I (~₹70 cr done, 10% threshold crossed so profits booked). Phase-II starts December with billing from next month; ~₹150 cr expected in FY26.
- Project selection discipline: The company restricts itself to Maharashtra and central government-funded projects due to state finance issues across India. It will work only for government clients with their own sources of funds (MCGM, MHADA, CIDCO), central government projects with budget-allocated funds through NBCC and central PSUs, EXIM Bank-funded projects in Maldives, and 10–12 existing private sector clients.
- Order book mix shifting: Going forward, more government projects are expected, with hardly any BOP tenders; all projects are now being requested on EPC basis. The private sector will continue on a BOP basis for the foreseeable future.
Margins & Profitability
- EBITDA guidance: Full-year range of 16.5% to 17.5%, excluding other income; expected to end at the higher trajectory, close to 17.5%.
- Margin drivers: Super high-rises command a premium over normal 30–40 floor buildings; Capacit'e is among the top three in the country for super high-rise. Asset turn improved from 2–2.5x to 5.4x (possibly close to 6x for the full year). Single-segment focus avoids heavier HR and equipment costs. Design-build projects that previously increased debtor levels are now delivering profitability and reducing working capital as a percentage of top line.
- Finance cost falling: On an absolute basis, finance cost will be lower than last financial year despite higher top line and higher bank guarantee utilization. In FY27, finance cost on higher utilization of ₹85 cr will reduce by ₹9 cr absolute; as a percentage of top line, it will be much lower, directly increasing cash profit. Bank interest rate on working capital reduced to 10.3% from Q3 onwards; bank guarantee and LC commissions reduced by ~75 bps per annum.
- Avendus debt repayment: Reduced from ₹100 cr to ₹57 cr as of September; a further ₹7.14 cr to be repaid in the current quarter. No plan to prepay beyond what is already scheduled.
- PAT outlook: On the higher end of the range; no reason to change because it is based on orders already with the company.
Katyal: "We are very conscious of the margins that the company will make, if not today, at least over the next three years. And therefore, we give guidance on the stability of our margins in the foreseeable future till the time the current order book pans out." [19–20]
Balance Sheet & Banking
- Promoter pledge reduction: Over the last 18 months, promoter pledge shares have been released by nearly 30%; expected to decline significantly further in coming quarters.
- Bank consortium expansion: New banks Punjab and Sind Bank and Jammu and Kashmir Bank joined the consortium; limits increased by Bank of Maharashtra and PNB; final SBI sanction is pending but interim financial tie-up is completed. Additional SBI limits may be utilized for project-specific incremental requirements.
- IT department survey: A survey was conducted at premises last month; the company clarified to stock exchanges that all support was provided, nothing material to inform, no impact on operations, and all sites are functioning normally. Data was provided as the survey was a fallback on a larger survey.
Operations & Execution
- Labor availability an industry-wide challenge: Total labor strength exceeds 12,000 but the company would like 14,000–15,000 for the next financial year. Competition from UAE, Middle East, and Eastern Europe for skilled workmen is intense. A separate Labor Resource Department works 24/7, and the company is adopting new technologies requiring lower workmen deployment. Management stated this will not hinder the 20% growth target for the current year.
- Execution scale-up confidence: The company had never done ₹650 cr in a monsoon season before; it is now targeting ₹725 cr for Q3 and ₹850 cr for March. October already achieved ₹240 cr.
- JV projects progressing: Mara JV is a 5–6 year project; revenues will come on a stabilized basis over the next five years, with momentum picking up in the next financial year. Bhandup Hospital Project JV uptick is expected in Q4 of the current financial year.
- Tallest building underway: Construction has started on a 320-meter building for Mala, a design-build integrated joint venture with Tata Projects.
- No diversification planned: The company will not diversify into water management or other segments; it will look into alternative technologies within its own segment. The entire ₹11,000 cr order book comes from this segment alone.
- CAPEX H2: Similar to H1, slightly lower; with new projects (NBCC, Signature Global), the company is looking at certain aluminum formwork.
Katyal: "We should not keep the issue under the carpet. Labor availability is a challenge right now from L&T to any other construction company, because of the depth of qualified skilled workmen in our country and we also face competition from UAE, Middle East, as well as Eastern Europe."
Competitive Positioning
- Qualified for large projects: Very few Indian building construction companies qualify for projects upward of ₹700, 800, or 1,000 cr; Capacit'e is one of them.
- Single-segment focus as advantage: Not being in two or three segments avoids heavier HR costs and monitoring overhead, and improves asset turns by eliminating the need for separate equipment sets.
- Accounting policy change: The change discussed in March has panned out over two quarters and will continue to be cyclical. No revenue has been booked yet on new projects (IIT, Downtown); that will start in Q4. Hardly any revenue has been booked on Indus (designing complete, only piling done). Going forward, it will be even-stevens.
Katyal: "There are a very few Indian building construction companies who qualify for projects upward of 700, 800 or 1,000 crores, and fortunately, Capacit'e is one of them who qualify."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Full-year revenue | ₹2,810 cr (20% growth) | FY26 |
| Full-year EBITDA margin | 16.5% to 17.5%, ending near 17.5% (excl. other income) | FY26 |
| Order inflow | Cross ₹3,500 cr target "quite decently" | FY26 |
| Receivables recovery | ₹65 cr total, including slow-moving assets and property sales | FY26 |
| Property sale proceeds | ₹30 cr from property sales | November–December 2025 |
| Debtor days reduction | Further 20–25 days reduction; return to pre-COVID levels | H2 FY26 / FY27-end |
| MHADA rehab towers | Five towers delivered | Early December 2025 |
| MHADA sale residential construction | Start construction | January/February 2026 |
| MHADA SPV revenue | Cross ₹1,000 cr+ | FY27 |
| MHADA full order book recognition | Entire project recognized (currently 35%) | March/April 2026 |
| CIDCO H2 billing | Build further ₹300 cr | H2 FY26 |
| CIDCO FY27 billing | Bill ₹720 cr, complete six locations | FY27 |
| CIDCO seventh location order | ~₹2,000 cr executable work, 42-month execution | Expected Q4 FY26 |
| IIT Bombay execution start | Start execution (design completion by December-end) | Q4 FY26 |
| Signature Global Phase-II | Start billing | December 2025 / next month |
| FY28 revenue target | ₹4,000 cr with 20–23% revenue growth | FY28 |
| Finance cost reduction | ₹9 cr absolute reduction on higher utilization of ₹85 cr | FY27 |
| Promoter pledge | Decline significantly further | Coming quarters |
| Avendus debt repayment | ₹7.14 cr repayment | Current quarter (Q3 FY26) |
Key Metrics
| Metric | Q2 FY26 |
|---|---|
| Total income | ₹650 cr, up 24% YoY from ₹523 cr |
| EBITDA | ₹108 cr, up 14% YoY from ₹95 cr |
| EBITDA margin | 16.8%, within guided range of 16.5%–17.5% excluding other income |
| EBIT | ₹89 cr, up 11% YoY from ₹79 cr |
| EBIT margin | 13.6% |
| PAT | ₹51 cr, up 14% YoY from ₹45 cr |
| PAT margin | 7.9% |
| Gross debt | ₹405 cr as on Sep 30, 2025, down from ₹417 cr as on Mar 31, 2025 |
| Gross debt-to-equity | 0.22x |
| Net debt-to-equity | 0.11x |
| Net asset turnover of core assets | 5.4x for H1 FY26 |
| Order book (standalone) | ₹11,991 cr as on Sep 30, 2025; public sector 60%, private sector 40% |
| Year-to-date order bookings | ₹3,464 cr, nearly achieving full-year guidance of ₹3,500 cr |
| Revenue guidance FY26 | ₹2,810 cr, targeting 20% growth; Q3 target ₹725 cr, March target ₹850 cr |
| EBITDA guidance FY26 | 16.5%–17.5% excluding other income; expected to end at higher end |
| Debtor days reduction | 21 days reduced in H1; targeting another 20–25 days reduction in H2 |
| Overall debtor level reduction | ₹90 cr |
| EPC vs BOP order book mix | 56%–57% EPC, 43%–44% BOP |
| Labor strength | In excess of 12,000; target 14,000–15,000 for next financial year |
| Average bank interest rate on working capital | 10.3% from Q3 onwards |
| Avendus high-cost debt outstanding | ₹57 cr as on Sep 2025, down from ₹100 cr; interest rate 13.8% |
| MHADA SPV revenue expectation FY27 | ₹1,000 cr plus |
| CIDCO first six locations total value | Close to ₹2,600 cr including price variation |
| CIDCO seventh location expected value | Close to ₹2,000 cr of executable work plus price variation, expected in Q4 FY26 |